{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:26:10Z","timestamp":1793831170270,"version":"4.6.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["LKM2022060"],"award-info":[{"award-number":["LKM2022060"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019974","name":"Nanning Science and Technology Bureau","doi-asserted-by":"publisher","award":["JC12022017"],"award-info":[{"award-number":["JC12022017"]}],"id":[{"id":"10.13039\/501100019974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200462"],"award-info":[{"award-number":["82200462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018YFA0801004"],"award-info":[{"award-number":["2018YFA0801004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.athplu.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T02:39:14Z","timestamp":1718073554000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["NAD+ metabolism and therapeutic strategies in cardiovascular diseases"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2012-2322","authenticated-orcid":false,"given":"Chongxu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2024.06.001_bib1","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American heart association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.athplu.2024.06.001_bib3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.121.056589","article-title":"NAD(+) metabolism in cardiac health, aging, and disease","volume":"144","author":"Abdellatif","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD(+) intermediates: the biology and therapeutic potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib6","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib7","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41467-019-12262-x","article-title":"Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage","volume":"10","author":"Sambeat","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2004.09.013","article-title":"Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)","volume":"95","author":"Canner","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154923","article-title":"Regulation of NAD(+) metabolism in aging and disease","volume":"126","author":"Chu","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.athplu.2024.06.001_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10409238.2015.1028612","article-title":"The human NAD metabolome: functions, metabolism and compartmentalization","volume":"50","author":"Nikiforov","year":"2015","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.athplu.2024.06.001_bib14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bbapap.2016.06.014","article-title":"NAD(+) metabolism: bioenergetics, signaling and manipulation for therapy","volume":"1864","author":"Yang","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.athplu.2024.06.001_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/jpet.107.120758","article-title":"NAD+ and vitamin B3: from metabolism to therapies","volume":"324","author":"Sauve","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.athplu.2024.06.001_bib16","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.15252\/embj.201797135","article-title":"Modulating NAD(+) metabolism, from bench to bedside","volume":"36","author":"Katsyuba","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.athplu.2024.06.001_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154733","article-title":"Beyond mitochondria: alternative energy-producing pathways from all strata of life","volume":"118","author":"Auger","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.athplu.2024.06.001_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.athplu.2024.06.001_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s42255-018-0009-4","article-title":"Slc12a8 is a nicotinamide mononucleotide transporter","volume":"1","author":"Grozio","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41581-019-0216-6","article-title":"NAD(+) homeostasis in renal health and disease","volume":"16","author":"Ralto","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.athplu.2024.06.001_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fphar.2018.00266","article-title":"Nanobody-based biologics for modulating purinergic signaling in inflammation and immunity","volume":"9","author":"Menzel","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.athplu.2024.06.001_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD(+) homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111569","article-title":"The balance between NAD(+) biosynthesis and consumption in ageing","volume":"199","author":"Str\u00f8mland","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.athplu.2024.06.001_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","article-title":"The mitochondrial acylome emerges: proteomics, regulation by sirtuins, and metabolic and disease implications","volume":"27","author":"Carrico","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib28","doi-asserted-by":"crossref","first-page":"H1371","DOI":"10.1152\/ajpheart.00024.2020","article-title":"Sirt1 during childhood is associated with microvascular function later in life","volume":"318","author":"Rodriguez-Miguelez","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib29","doi-asserted-by":"crossref","first-page":"H484","DOI":"10.1152\/ajpheart.00548.2017","article-title":"Endothelial dysfunction is a superinducer of syndecan-4: fibrogenic role of its ectodomain","volume":"314","author":"Lipphardt","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmet.2012.06.016","article-title":"The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease","volume":"16","author":"Bai","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.athplu.2024.06.001_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/nar\/gkh215","article-title":"Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2","volume":"32","author":"Oliver","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib32","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1073\/pnas.1016574108","article-title":"Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression","volume":"108","author":"Boehler","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.athplu.2024.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174162","article-title":"PARP1: liaison of chromatin remodeling and transcription","volume":"14","author":"Zong","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.athplu.2024.06.001_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.gde.2021.07.005","article-title":"Serine ADP-ribosylation in DNA-damage response regulation","volume":"71","author":"Palazzo","year":"2021","journal-title":"Curr Opin Genet {\\&} Dev"},{"key":"10.1016\/j.athplu.2024.06.001_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcdb.2016.12.009","article-title":"Metabolic roles of poly(ADP-ribose) polymerases","volume":"63","author":"Vida","year":"2017","journal-title":"Semin Cell {\\&} Dev Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","article-title":"Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease","volume":"173","author":"Pacher","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.athplu.2024.06.001_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib39","doi-asserted-by":"crossref","first-page":"28951","DOI":"10.1074\/jbc.M604370200","article-title":"Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities","volume":"281","author":"Graeff","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.athplu.2024.06.001_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0014-5793(99)00913-8","article-title":"Hydrolysis of NADP+ by platelet CD38 in the absence of synthesis and degradation of cyclic ADP-ribose 2\u2019-phosphate","volume":"455","author":"Torti","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.athplu.2024.06.001_bib41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib42","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1038\/srep03652","article-title":"Novel SCRG1\/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells","volume":"4","author":"Aomatsu","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2024.06.001_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.abb.2014.09.008","article-title":"A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157","volume":"564","author":"Preugschat","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.athplu.2024.06.001_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415722","article-title":"Endothelial dysfunction and chronic inflammation: the cornerstones of vascular alterations in age-related diseases","volume":"23","author":"Pacinella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.athplu.2024.06.001_bib45","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/FJC.0000000000001154","article-title":"Endothelial SIRT1 as a target for the prevention of arterial aging: promises and challenges","volume":"78","author":"Begum","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.athplu.2024.06.001_bib46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng1295-376","article-title":"Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase","volume":"11","author":"Li","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.athplu.2024.06.001_bib47","first-page":"116","article-title":"Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension","volume":"55","author":"Ardanaz","year":"2010","journal-title":"Hypertens (Dallas, Tex 1979"},{"key":"10.1016\/j.athplu.2024.06.001_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-079X.2008.00654.x","article-title":"Prevention of ischemia\/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1","volume":"46","author":"Chen","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yexcr.2018.09.010","article-title":"Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy","volume":"372","author":"Hu","year":"2018","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib50","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.114.012725","article-title":"Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function","volume":"131","author":"Huang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.athplu.2024.06.001_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/acel.12461","article-title":"Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice","volume":"15","author":"de Picciotto","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2018.05.073","article-title":"Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis","volume":"123","author":"Hong","year":"2018","journal-title":"Free Radic Biol {\\&} Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101192","article-title":"Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice","volume":"24","author":"Tarantini","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11357-020-00165-5","article-title":"Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects","volume":"42","author":"Kiss","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.athplu.2024.06.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105125","article-title":"Role of hydrogen sulfide in cardiovascular ageing","volume":"160","author":"Testai","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7543973","article-title":"Sirt1 inhibits oxidative stress in vascular endothelial cells","volume":"2017","author":"Zhang","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.athplu.2024.06.001_bib58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jnr.24397","article-title":"Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice","volume":"97","author":"Klimova","year":"2019","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11357-019-00095-x","article-title":"Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects","volume":"41","author":"Kiss","year":"2019","journal-title":"GeroScience"},{"key":"10.1016\/j.athplu.2024.06.001_bib60","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib61","doi-asserted-by":"crossref","first-page":"C297","DOI":"10.1152\/ajpcell.00139.2017","article-title":"Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion","volume":"314","author":"Boslett","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib62","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib63","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib64","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","article-title":"Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages","volume":"2","author":"Covarrubias","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib65","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3389\/fimmu.2018.01593","article-title":"CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions","volume":"9","author":"Amici","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.athplu.2024.06.001_bib66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ymgme.2011.12.016","article-title":"Population variability in CD38 activity: correlation with age and significant effect of TNF-\u03b1 -308G>A and CD38 184C>G SNPs","volume":"105","author":"Polzonetti","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1753425915602545","article-title":"Nicotinamide: a vitamin able to shift macrophage differentiation toward macrophages with restricted inflammatory features","volume":"21","author":"Weiss","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.athplu.2024.06.001_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cmet.2018.02.001","article-title":"Nicotinamide improves aspects of healthspan, but not lifespan, in mice","volume":"27","author":"Mitchell","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.116.238261","article-title":"Niacin promotes cardiac healing after myocardial infarction through activation of the myeloid prostaglandin D(2) receptor subtype 1","volume":"360","author":"Kong","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.athplu.2024.06.001_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114019","article-title":"Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside","volume":"178","author":"Mateuszuk","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.athplu.2024.06.001_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCRESAHA.118.312208","article-title":"Autophagy in cardiovascular aging","volume":"123","author":"Abdellatif","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib72","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1080\/15548627.2018.1501132","article-title":"Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis","volume":"14","author":"Osonoi","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.athplu.2024.06.001_bib73","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1113\/jphysiol.2012.229690","article-title":"Translational evidence that impaired autophagy contributes to arterial ageing","volume":"590","author":"LaRocca","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00395-020-0817-z","article-title":"NAD(+) administration decreases microvascular damage following cardiac ischemia\/reperfusion by restoring autophagic flux","volume":"115","author":"Zhang","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib75","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.0712145105","article-title":"A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy","volume":"105","author":"Lee","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.athplu.2024.06.001_bib76","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib77","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/ATVBAHA.114.304794","article-title":"Macrophages","volume":"34","author":"Mallat","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib78","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.07.032","article-title":"SIRT1 deacetylates and positively regulates the nuclear receptor LXR","volume":"28","author":"Li","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2017.08.027","article-title":"The sirtuin family members SIRT1, SIRT3 and SIRT6: their role in vascular biology and atherogenesis","volume":"265","author":"Sosnowska","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2024.06.001_bib81","article-title":"Nicotinamide prevents apolipoprotein B-containing lipoprotein oxidation, inflammation and atherosclerosis in apolipoprotein E-deficient mice","volume":"9","author":"M\u00e9ndez-Lara","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.athplu.2024.06.001_bib82","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/HYPERTENSIONAHA.111.183210","article-title":"Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels","volume":"59","author":"Domagala","year":"2012","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.athplu.2024.06.001_bib83","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/jpet.115.228643","article-title":"Antiatherosclerotic effects of 1-methylnicotinamide in apolipoprotein E\/low-density lipoprotein receptor-deficient mice: a comparison with nicotinic acid","volume":"356","author":"Mateuszuk","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.athplu.2024.06.001_bib84","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/mnfr.201501019","article-title":"N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice","volume":"60","author":"Jiang","year":"2016","journal-title":"Mol Nutr {\\&} Food Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib85","article-title":"NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2024.06.001_bib86","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/ATVBAHA.116.308187","article-title":"Leukocyte overexpression of intracellular NAMPT attenuates atherosclerosis by regulating PPAR$\u03b3$-Dependent monocyte differentiation and function","volume":"37","author":"Bermudez","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib87","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41401-018-0207-3","article-title":"Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice","volume":"40","author":"Kong","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.athplu.2024.06.001_bib88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2012.01.007","article-title":"NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia","volume":"512","author":"Zheng","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.athplu.2024.06.001_bib89","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/med.21300","article-title":"Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications","volume":"34","author":"Xu","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.athplu.2024.06.001_bib90","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.106.668756","article-title":"Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death","volume":"115","author":"Oumouna-Benachour","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib91","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cvr\/cvm110","article-title":"PARP1 is required for adhesion molecule expression in atherogenesis","volume":"78","author":"von Lukowicz","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib92","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/jpet.108.145938","article-title":"Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content","volume":"329","author":"Hans","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.athplu.2024.06.001_bib93","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/15384101.2019.1640008","article-title":"PJ34, a PARP1 inhibitor, promotes endothelial repair in a rabbit model of high fat diet-induced atherosclerosis","volume":"18","author":"Zha","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.athplu.2024.06.001_bib94","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10517-008-0268-2","article-title":"Effect of nadcin on energy supply system and apoptosis in ischemia-reperfusion injury to the myocardium","volume":"146","author":"V Sukoyan","year":"2008","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib95","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10517-005-0208-3","article-title":"Effect of NAD on recovery of adenine nucleotide pool, phosphorylation potential, and stimulation of apoptosis during late period of reperfusion damage to myocardium","volume":"139","author":"V Sukoyan","year":"2005","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib96","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF03402187","article-title":"Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase","volume":"7","author":"Liaudet","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib97","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1073\/pnas.1505556112","article-title":"Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart","volume":"112","author":"Reyes","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.athplu.2024.06.001_bib98","first-page":"3342","article-title":"Exogenous NAD(+) administration significantly protects against myocardial ischemia\/reperfusion injury in rat model","volume":"8","author":"Zhang","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib99","article-title":"Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2024.06.001_bib100","article-title":"CDR1as promotes arrhythmias in myocardial infarction via targeting the NAMPT-NAD(+) pathway","volume":"165","author":"Liu","year":"2023","journal-title":"Biomed {\\&} Pharmacother = Biomed {\\&} Pharmacother"},{"key":"10.1016\/j.athplu.2024.06.001_bib101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","article-title":"Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes","volume":"105","author":"Hsu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib102","first-page":"6066","article-title":"Exogenous supplemental NAD+ protect myocardium against myocardial ischemic\/reperfusion injury in swine model","volume":"11","author":"Zhai","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib103","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.phrs.2010.01.008","article-title":"Nicotinamide-rich diet protects the heart against ischaemia-reperfusion in mice: a crucial role for cardiac SUR2A","volume":"61","author":"Sukhodub","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1074248419882002","article-title":"Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia\/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats","volume":"25","author":"Hosseini","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.athplu.2024.06.001_bib105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-021-00625-0","article-title":"CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice","volume":"6","author":"Gan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.athplu.2024.06.001_bib106","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","article-title":"NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice","volume":"352","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.athplu.2024.06.001_bib107","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","article-title":"CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels","volume":"2","author":"Chini","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib108","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110888","article-title":"Age-related NAD(+) decline","volume":"134","author":"McReynolds","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.athplu.2024.06.001_bib110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","article-title":"The NAD(+)\/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling","volume":"154","author":"Mouchiroud","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib111","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2019.05.015","article-title":"Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice","volume":"30","author":"Yoshida","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib112","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cell.2016.07.031","article-title":"Metabolic control of longevity","volume":"166","author":"L\u00f3pez-Ot\u00edn","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2020.11.034","article-title":"Hallmarks of health","volume":"184","author":"L\u00f3pez-Ot\u00edn","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib114","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbrc.2003.08.105","article-title":"Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses","volume":"309","author":"Leonard","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/biof.1399","article-title":"Role of resveratrol in regulation of cellular defense systems against oxidative stress","volume":"44","author":"Truong","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.athplu.2024.06.001_bib116","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-13-0171","article-title":"Resveratrol and cancer: focus on in vivo evidence","volume":"21","author":"Carter","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.athplu.2024.06.001_bib117","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-3-319-09614-8_19","article-title":"A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma","volume":"815","author":"Shrotriya","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib118","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12837","article-title":"Resveratrol in the treatment of pancreatic cancer","volume":"1348","author":"Xu","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.athplu.2024.06.001_bib119","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bbadis.2015.01.012","article-title":"Lifespan and healthspan extension by resveratrol","volume":"1852","author":"Bhullar","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.athplu.2024.06.001_bib120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/biof.1400","article-title":"Effect of resveratrol and pterostilbene on aging and longevity","volume":"44","author":"Li","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.athplu.2024.06.001_bib121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.athplu.2024.06.001_bib122","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nature02789","article-title":"Sirtuin activators mimic caloric restriction and delay ageing in metazoans","volume":"430","author":"Wood","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.athplu.2024.06.001_bib123","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.athplu.2024.06.001_bib124","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/c54ef754-1962-4125-bf19-76d3ec6f19e5","article-title":"A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice","volume":"3","author":"Barger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2024.06.001_bib126","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.athplu.2024.06.001_bib127","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.devcel.2008.02.004","article-title":"Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt","volume":"14","author":"Fulco","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib128","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.athplu.2024.06.001_bib129","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.yexcr.2007.12.012","article-title":"Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression","volume":"314","author":"Ivanov","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib130","doi-asserted-by":"crossref","first-page":"27628","DOI":"10.1074\/jbc.M805711200","article-title":"SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation","volume":"283","author":"Lan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.athplu.2024.06.001_bib131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.04.019","article-title":"Xenohormesis: sensing the chemical cues of other species","volume":"133","author":"Howitz","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib133","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib134","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.athplu.2024.06.001_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158258","article-title":"Prospective pharmacological potential of resveratrol in delaying kidney aging","volume":"22","author":"Uddin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.athplu.2024.06.001_bib136","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.01.043","article-title":"The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system","volume":"270","author":"Kim","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2024.06.001_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111226","article-title":"Resveratrol: change of SIRT 1 and AMPK signaling pattern during the aging process","volume":"146","author":"Caldeira","year":"2021","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.athplu.2024.06.001_bib138","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers","volume":"12","author":"Airhart","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2024.06.001_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.athplu.2024.06.001_bib141","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1172\/JCI138538","article-title":"Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure","volume":"130","author":"Zhou","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.athplu.2024.06.001_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13754","article-title":"Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin","volume":"22","author":"Vreones","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.athplu.2024.06.001_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.881703","article-title":"Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in midlife and older adults","volume":"9","author":"Freeberg","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.athplu.2024.06.001_bib144","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD(+) metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.athplu.2024.06.001_bib145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacbts.2022.06.012","article-title":"Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction","volume":"7","author":"Wang","year":"2022","journal-title":"JACC Basic to Transl Sci"},{"key":"10.1016\/j.athplu.2024.06.001_bib146","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1194\/jlr.S092007","article-title":"Niacin: an old lipid drug in a new NAD(+) dress","volume":"60","author":"Romani","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.athplu.2024.06.001_bib147","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12012-016-9387-6","article-title":"Cardiotoxicity associated with nicotinamide phosphoribosyltransferase inhibitors in rodents and in rat and human-derived cells lines","volume":"17","author":"Misner","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.athplu.2024.06.001_bib148","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2024.06.001_bib149","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/eurheartj\/ehl525","article-title":"Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration","volume":"28","author":"Frustaci","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2024.06.001_bib150","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2024.06.001_bib151","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202856","article-title":"Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide","volume":"40","author":"Badawy","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.athplu.2024.06.001_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110044","article-title":"COVID-19: NAD(+) deficiency may predispose the aged, obese and type 2 diabetics to mortality through its effect on SIRT1 activity","volume":"144","author":"Miller","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.athplu.2024.06.001_bib153","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jiph.2020.06.004","article-title":"Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: a hypothesis","volume":"13","author":"Omran","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.athplu.2024.06.001_bib154","doi-asserted-by":"crossref","first-page":"33","DOI":"10.34067\/KID.0006452020","article-title":"Niacinamide may Be associated with improved outcomes in COVID-19-related acute kidney injury: an observational study","volume":"2","author":"Raines","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.athplu.2024.06.001_bib155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","article-title":"Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice","volume":"24","author":"Mills","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.athplu.2024.06.001_bib156","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12970-021-00442-4","article-title":"Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study","volume":"18","author":"Liao","year":"2021","journal-title":"J Int Soc Sports Nutr"},{"key":"10.1016\/j.athplu.2024.06.001_bib157","doi-asserted-by":"crossref","DOI":"10.1242\/jeb.242425","article-title":"Activation of cardiac Nmnat\/NAD+\/SIR2 pathways mediates endurance exercise resistance to lipotoxic cardiomyopathy in aging Drosophila","volume":"224","author":"Wen","year":"2021","journal-title":"J Exp Biol"},{"key":"10.1016\/j.athplu.2024.06.001_bib158","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","article-title":"Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men","volume":"67","author":"Irie","year":"2020","journal-title":"Endocr J"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089524000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089524000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T19:39:00Z","timestamp":1728070740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089524000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":158,"alternative-id":["S2667089524000142"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2024.06.001","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAD+ metabolism and therapeutic strategies in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}